GOSS

Gossamer Bio, Inc.CIK 1728117 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for GOSS PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for GOSS

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Ciongoli Gregory Austin	Director	2	$0	$0	2026-09-23
Nathan Steven D	Director	5	$0	$0	2026-09-23
Drynan Skye	Director	5	$0	$0	2026-09-23
Milligan Sandra	Director	10	$75.3K	$0	2026-09-23
Quisel John D	Director	6	$0	$0	2026-09-23
Daniel Thomas O	Director	12	$0	$0	2026-09-23
Cox Russell J.	Director	11	$115.2K	$0	2026-09-23
Smith Robert Paul JR	Chief Commercial Officer	12	$15.0K	$0	2026-08-24
Peterson Caryn	EVP, Regulatory Affairs	54	$0	$152.2K	2026-08-24
Giraudo Bryan	Chief Financial Officer	69	$565.1K	$155.1K	2026-08-24
Christian Waage	EVP, Tech Ops and Admin	56	$137.5K	$155.1K	2026-08-24
Hasnain Faheem	President & CEO, Director	52	$3.42M	$196.7K	2026-08-24
Aranda Richard	Chief Medical Officer	55	$0	$168.0K	2026-03-19
GALA RENEE D	Director	5	$0	$0	2023-06-08
Burow Kristina	Director	13	$0	$0	2023-06-08
Carter Laura	Chief Scientific Officer	14	$50.0K	$276.6K	2023-03-20
Bilenker Joshua H.	Director	4	$0	$0	2022-06-09
Salter-Cid Luisa	Chief Scientific Officer	9	$0	$1.05M	2021-03-23
Gujrathi Sheila	President & CEO	7	$168.0K	$0	2020-02-14
Dupont Jakob	Chief Medical Officer	9	$0	$631.5K	2020-02-14
Omega Fund V GP Manager, Ltd.	10% Owner	3	$0	$4.49M	2019-09-20
Omega Fund V, L.P.	10% Owner	3	$0	$1.79M	2019-09-18
Stampacchia Otello	Director, 10% Owner	7	$0	$2.39M	2019-09-11
ARCH Venture Partners IX, L.P.	10% Owner	8	$0	$0	2019-02-12

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Nathan Steven D	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Cox Russell J.	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Quisel John D	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Drynan Skye	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Ciongoli Gregory Austin	Director	A Award deriv	2026-09-23	2026-09-25	30,000	—	$0	30,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Milligan Sandra	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Milligan Sandra	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Quisel John D	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Nathan Steven D	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Drynan Skye	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Cox Russell J.	Director	A Award deriv	2026-09-23	2026-09-25	10,000	—	$0	10,000	SEC↗
Ciongoli Gregory Austin	Director	A Award deriv	2026-09-23	2026-09-25	30,000	—	$0	30,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-08-24	2026-08-26	166	$1000.00	$166.0K	166	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-08-24	2026-08-26	25	$1000.00	$25.0K	25	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Peterson Caryn	Chief Development Officer	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-08-24	2026-08-26	2,900,026	—	$0	2,900,026	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Peterson Caryn	Chief Development Officer	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Hasnain Faheem	President & CEO, Director	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Hasnain Faheem	President & CEO, Director	A Award deriv	2026-08-24	2026-08-26	166	$1000.00	$166.0K	166	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-08-24	2026-08-26	5,800,051	—	$0	5,800,051	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-08-24	2026-08-26	25	$1000.00	$25.0K	25	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-08-24	2026-08-26	2,900,026	—	$0	2,900,026	SEC↗
Nathan Steven D	Director	A Award deriv	2026-06-04	2026-06-05	115,000	—	$0	115,000	SEC↗
Milligan Sandra	Director	A Award deriv	2026-06-04	2026-06-05	115,000	—	$0	115,000	SEC↗
Cox Russell J.	Director	A Award deriv	2026-06-04	2026-06-05	115,000	—	$0	115,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2026-06-04	2026-06-05	115,000	—	$0	115,000	SEC↗
Drynan Skye	Director	A Award deriv	2026-06-04	2026-06-05	115,000	—	$0	115,000	SEC↗
Quisel John D	Director	A Award deriv	2026-06-04	2026-06-05	115,000	—	$0	115,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	70,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	126,667	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	157,500	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	157,500	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	125,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	375,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	440,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	506,250	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	70,000	—	$0	70,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	47,667	—	$0	47,667	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	60,000	—	$0	60,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	126,667	—	$0	126,667	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	157,500	—	$0	157,500	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	157,500	—	$0	157,500	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	125,000	—	$0	125,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	375,000	—	$0	375,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	440,000	—	$0	440,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-03-19	2026-03-20	506,250	—	$0	506,250	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	60,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2026-03-19	2026-03-20	47,667	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	96,667	—	$0	96,667	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	47,667	—	$0	47,667	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	60,000	—	$0	60,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	100,000	—	$0	100,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	176,667	—	$0	176,667	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	211,500	—	$0	211,500	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	211,500	—	$0	211,500	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	181,250	—	$0	181,250	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	543,750	—	$0	543,750	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	638,000	—	$0	638,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-03-19	2026-03-20	693,750	—	$0	693,750	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	96,667	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	47,667	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	60,000	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	100,000	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	176,667	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	211,500	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	211,500	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	181,250	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	543,750	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	638,000	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2026-03-19	2026-03-20	693,750	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	1,312,500	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	1,540,000	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	1,680,000	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	43,500	—	$0	43,500	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	47,000	—	$0	47,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	325,000	—	$0	325,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	650,000	—	$0	650,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	544,500	—	$0	544,500	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	544,500	—	$0	544,500	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	437,500	—	$0	437,500	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	1,312,500	—	$0	1,312,500	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	1,540,000	—	$0	1,540,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-03-19	2026-03-20	1,680,000	—	$0	1,680,000	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	43,500	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	47,000	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	325,000	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	650,000	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	544,500	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	437,500	—	$0	0	SEC↗
Hasnain Faheem	President & CEO	D To issuer deriv	2026-03-19	2026-03-20	544,500	—	$0	0	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2026-03-19	2026-03-20	572,000	—	$0	572,000	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	D To issuer deriv	2026-03-19	2026-03-20	562,500	—	$0	0	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	D To issuer deriv	2026-03-19	2026-03-20	572,000	—	$0	0	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2026-03-19	2026-03-20	562,500	—	$0	562,500	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	21,167	—	$0	21,167	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	126,667	—	$0	126,667	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	157,500	—	$0	157,500	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	157,500	—	$0	157,500	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	125,000	—	$0	125,000	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	375,000	—	$0	375,000	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	440,000	—	$0	440,000	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	506,250	—	$0	506,250	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	32,334	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	9,167	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	22,784	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	18,834	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	21,167	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	126,667	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	157,500	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	157,500	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	125,000	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	375,000	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	440,000	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2026-03-19	2026-03-20	506,250	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	32,334	—	$0	32,334	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	18,834	—	$0	18,834	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	9,167	—	$0	9,167	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-03-19	2026-03-20	22,784	—	$0	22,784	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	126,667	—	$0	126,667	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	162,500	—	$0	162,500	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	487,500	—	$0	487,500	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	572,000	—	$0	572,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	562,500	—	$0	562,500	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	30,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	9,167	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	22,784	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	40,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	20,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	126,667	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	157,500	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	157,500	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	162,500	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	487,500	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	572,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2026-03-19	2026-03-20	562,500	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	30,000	—	$0	30,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	9,167	—	$0	9,167	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	22,784	—	$0	22,784	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	40,000	—	$0	40,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	20,000	—	$0	20,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	157,500	—	$0	157,500	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-03-19	2026-03-20	157,500	—	$0	157,500	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2026-01-02	2026-01-05	506,250	—	$0	506,250	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2026-01-02	2026-01-05	506,250	—	$0	506,250	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2026-01-02	2026-01-05	562,500	—	$0	562,500	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2026-01-02	2026-01-05	562,500	—	$0	562,500	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2026-01-02	2026-01-05	693,750	—	$0	693,750	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2026-01-02	2026-01-05	1,680,000	—	$0	1,680,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award	2026-01-02	2026-01-05	84,500	—	$0	814,061	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award	2026-01-02	2026-01-05	84,500	—	$0	259,333	SEC↗
Aranda Richard	Chief Medical Officer	A Award	2026-01-02	2026-01-05	93,750	—	$0	463,106	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award	2026-01-02	2026-01-05	93,750	—	$0	260,898	SEC↗
Giraudo Bryan	COO/CFO	A Award	2026-01-02	2026-01-05	115,750	—	$0	389,737	SEC↗
Hasnain Faheem	President & CEO	A Award	2026-01-02	2026-01-05	280,000	—	$0	837,793	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award	2025-10-01	2025-10-02	125,000	—	$0	174,833	SEC↗
Hasnain Faheem	President & CEO	A Award	2025-10-01	2025-10-02	437,500	—	$0	557,793	SEC↗
Aranda Richard	Chief Medical Officer	A Award	2025-10-01	2025-10-02	162,500	—	$0	369,356	SEC↗
Giraudo Bryan	COO/CFO	A Award	2025-10-01	2025-10-02	181,250	—	$0	273,987	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award	2025-10-01	2025-10-02	125,000	—	$0	710,934	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award	2025-10-01	2025-10-02	162,500	—	$0	162,500	SEC↗
Milligan Sandra	Director	P Buy	2025-08-19	2025-08-20	26,050	$1.92	$50.0K	58,050	SEC↗
Drynan Skye	Director	A Award deriv	2025-06-25	2025-06-26	115,000	—	$0	115,000	SEC↗
Milligan Sandra	Director	A Award deriv	2025-06-25	2025-06-26	115,000	—	$0	115,000	SEC↗
Quisel John D	Director	A Award deriv	2025-06-25	2025-06-26	115,000	—	$0	115,000	SEC↗
Cox Russell J.	Director	A Award deriv	2025-06-25	2025-06-26	115,000	—	$0	115,000	SEC↗
Nathan Steven D	Director	A Award deriv	2025-06-25	2025-06-26	115,000	—	$0	115,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2025-06-25	2025-06-26	115,000	—	$0	115,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2025-03-04	2025-03-06	1,540,000	—	$0	1,540,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2025-03-04	2025-03-06	638,000	—	$0	638,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2025-03-04	2025-03-06	572,000	—	$0	572,000	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2025-03-04	2025-03-06	572,000	—	$0	572,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2025-03-04	2025-03-06	440,000	—	$0	440,000	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2025-03-04	2025-03-06	440,000	—	$0	440,000	SEC↗
Aranda Richard	Chief Medical Officer	S Sale	2024-06-24	2024-06-25	1,908	$0.66	$1.3K	196,891	SEC↗
Hasnain Faheem	President & CEO	P Buy	2024-06-21	2024-06-24	372,000	$0.67	$249.2K	5,408,073	SEC↗
Giraudo Bryan	COO/CFO	P Buy	2024-06-18	2024-06-20	100,000	$0.59	$59.0K	480,010	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	P Buy	2024-06-17	2024-06-20	25,000	$0.60	$15.0K	25,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2024-06-06	2024-06-06	115,000	—	$0	115,000	SEC↗
Cox Russell J.	Director	A Award deriv	2024-06-06	2024-06-06	115,000	—	$0	115,000	SEC↗
Milligan Sandra	Director	A Award deriv	2024-06-06	2024-06-06	115,000	—	$0	115,000	SEC↗
Quisel John D	Director	A Award deriv	2024-06-06	2024-06-06	115,000	—	$0	115,000	SEC↗
Hasnain Faheem	President & CEO	S Sale	2024-03-27	2024-03-28	23,172	$1.16	$26.9K	120,293	SEC↗
Giraudo Bryan	COO/CFO	S Sale	2024-03-27	2024-03-28	6,430	$1.16	$7.5K	92,737	SEC↗
Christian Waage	EVP, Tech Ops and Admin	S Sale	2024-03-27	2024-03-28	6,430	$1.16	$7.5K	585,934	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	S Sale	2024-03-18	2024-03-19	4,018	$1.33	$5.3K	49,833	SEC↗
Aranda Richard	Chief Medical Officer	S Sale	2024-03-18	2024-03-19	4,018	$1.33	$5.3K	198,799	SEC↗
Nathan Steven D	Director	A Award deriv	2024-03-11	2024-03-12	230,000	—	$0	230,000	SEC↗
Drynan Skye	Director	A Award deriv	2024-03-11	2024-03-12	230,000	—	$0	230,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2024-01-02	2024-01-04	1,312,500	—	$0	1,312,500	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2024-01-02	2024-01-04	543,750	—	$0	543,750	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2024-01-02	2024-01-04	487,500	—	$0	487,500	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2024-01-02	2024-01-04	375,000	—	$0	375,000	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2024-01-02	2024-01-04	375,000	—	$0	375,000	SEC↗
Smith Robert Paul JR	Chief Commercial Officer	A Award deriv	2023-12-04	2023-12-05	1,500,000	—	$0	1,500,000	SEC↗
Quisel John D	Director	A Award deriv	2023-11-28	2023-11-29	230,000	—	$0	230,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-11-20	2023-11-22	125,000	—	$0	125,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2023-11-20	2023-11-22	437,500	—	$0	437,500	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-11-20	2023-11-22	125,000	—	$0	125,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-11-20	2023-11-22	181,250	—	$0	181,250	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-11-20	2023-11-22	162,500	—	$0	162,500	SEC↗
Milligan Sandra	Director	P Buy	2023-11-15	2023-11-17	32,000	$0.79	$25.3K	32,000	SEC↗
Giraudo Bryan	COO/CFO	P Buy	2023-11-13	2023-11-14	200,000	$0.56	$112.0K	380,010	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-07-24	2023-07-26	3,376	$0.13	$439	3,376	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2023-07-24	2023-07-26	135,044	$0.13	$17.6K	135,044	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-07-24	2023-07-26	13,505	$0.13	$1.8K	13,505	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award	2023-07-24	2023-07-26	13,504	$1.82	$24.6K	45,892	SEC↗
Hasnain Faheem	President & CEO	A Award	2023-07-24	2023-07-26	540,176	$1.82	$983.1K	5,036,073	SEC↗
Giraudo Bryan	COO/CFO	A Award	2023-07-24	2023-07-26	54,020	$1.82	$98.3K	180,010	SEC↗
Aranda Richard	Chief Medical Officer	S Sale	2023-06-22	2023-06-26	1,814	$1.29	$2.3K	197,574	SEC↗
Burow Kristina	Director	A Award deriv	2023-06-08	2023-06-09	35,000	—	$0	35,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2023-06-08	2023-06-09	35,000	—	$0	35,000	SEC↗
Milligan Sandra	Director	A Award deriv	2023-06-08	2023-06-09	35,000	—	$0	35,000	SEC↗
Cox Russell J.	Director	A Award deriv	2023-06-08	2023-06-09	35,000	—	$0	35,000	SEC↗
GALA RENEE D	Director	A Award deriv	2023-06-08	2023-06-09	35,000	—	$0	35,000	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2023-05-05	2023-05-09	750,000	—	$0	750,000	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2023-05-05	2023-05-09	265,000	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-05-05	2023-05-09	100,000	—	$0	100,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-05-05	2023-05-09	60,000	—	$0	60,000	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-05-05	2023-05-09	47,667	—	$0	47,667	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-05-05	2023-05-09	96,667	—	$0	96,667	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-05-05	2023-05-09	176,667	—	$0	176,667	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2023-05-05	2023-05-09	150,000	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2023-05-05	2023-05-09	90,000	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2023-05-05	2023-05-09	71,500	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	D To issuer deriv	2023-05-05	2023-05-09	145,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-05-05	2023-05-09	60,000	—	$0	60,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-05-05	2023-05-09	126,667	—	$0	126,667	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-05-05	2023-05-09	47,667	—	$0	47,667	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2023-05-05	2023-05-09	105,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-05-05	2023-05-09	70,000	—	$0	70,000	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2023-05-05	2023-05-09	190,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2023-05-05	2023-05-09	90,000	—	$0	0	SEC↗
Christian Waage	EVP, Tech Ops and Admin	D To issuer deriv	2023-05-05	2023-05-09	71,500	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2023-05-05	2023-05-09	30,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2023-05-05	2023-05-09	45,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2023-05-05	2023-05-09	13,750	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-05-05	2023-05-09	20,000	—	$0	20,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-05-05	2023-05-09	40,000	—	$0	40,000	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-05-05	2023-05-09	22,784	—	$0	22,784	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-05-05	2023-05-09	9,167	—	$0	9,167	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-05-05	2023-05-09	30,000	—	$0	30,000	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2023-05-05	2023-05-09	190,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-05-05	2023-05-09	126,667	—	$0	126,667	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2023-05-05	2023-05-09	60,000	—	$0	0	SEC↗
Aranda Richard	Chief Medical Officer	D To issuer deriv	2023-05-05	2023-05-09	34,175	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2023-05-05	2023-05-09	34,175	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2023-05-05	2023-05-09	13,750	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2023-05-05	2023-05-09	48,500	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-05-05	2023-05-09	126,667	—	$0	126,667	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-05-05	2023-05-09	21,167	—	$0	21,167	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-05-05	2023-05-09	18,834	—	$0	18,834	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-05-05	2023-05-09	22,784	—	$0	22,784	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-05-05	2023-05-09	9,167	—	$0	9,167	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-05-05	2023-05-09	32,334	—	$0	32,334	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2023-05-05	2023-05-09	190,000	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2023-05-05	2023-05-09	31,750	—	$0	0	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	D To issuer deriv	2023-05-05	2023-05-09	28,250	—	$0	0	SEC↗
Giraudo Bryan	COO/CFO	P Buy	2023-04-04	2023-04-05	55,000	$1.02	$56.1K	125,990	SEC↗
Hasnain Faheem	President & CEO	P Buy	2023-03-22	2023-03-22	440,500	$1.14	$502.2K	4,495,897	SEC↗
Hasnain Faheem	President & CEO	P Buy	2023-03-21	2023-03-22	269,389	$1.20	$323.3K	4,055,397	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2023-03-20	2023-03-22	544,500	—	$0	544,500	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2023-03-20	2023-03-22	211,500	—	$0	211,500	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2023-03-20	2023-03-22	157,500	—	$0	157,500	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2023-03-20	2023-03-22	157,500	—	$0	157,500	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2023-03-20	2023-03-22	157,500	—	$0	157,500	SEC↗
Carter Laura	Chief Scientific Officer	A Award deriv	2023-03-20	2023-03-22	157,500	—	$0	157,500	SEC↗
Hasnain Faheem	President & CEO	P Buy	2023-03-20	2023-03-22	168,683	$1.03	$173.7K	3,786,008	SEC↗
Giraudo Bryan	COO/CFO	P Buy	2023-03-20	2023-03-22	50,000	$0.97	$48.5K	70,990	SEC↗
Christian Waage	EVP, Tech Ops and Admin	P Buy	2023-03-20	2023-03-22	18,500	$1.20	$22.2K	32,388	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	S Sale	2023-03-16	2023-03-20	7,564	$1.10	$8.3K	53,851	SEC↗
Aranda Richard	Chief Medical Officer	S Sale	2023-03-16	2023-03-20	7,563	$1.10	$8.3K	199,388	SEC↗
Carter Laura	Chief Scientific Officer	S Sale	2023-03-16	2023-03-20	6,029	$1.10	$6.6K	76,263	SEC↗
Hasnain Faheem	President & CEO	A Award deriv	2022-12-07	2022-12-09	544,500	—	$0	544,500	SEC↗
Giraudo Bryan	COO/CFO	A Award deriv	2022-12-07	2022-12-09	211,500	—	$0	211,500	SEC↗
Christian Waage	EVP, Tech Ops and Admin	A Award deriv	2022-12-07	2022-12-09	157,500	—	$0	157,500	SEC↗
Aranda Richard	Chief Medical Officer	A Award deriv	2022-12-07	2022-12-09	157,500	—	$0	157,500	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	A Award deriv	2022-12-07	2022-12-09	157,500	—	$0	157,500	SEC↗
Carter Laura	Chief Scientific Officer	A Award deriv	2022-12-07	2022-12-09	157,500	—	$0	157,500	SEC↗
Aranda Richard	Chief Medical Officer	S Sale	2022-10-24	2022-10-25	4,757	$12.07	$57.4K	205,430	SEC↗
Carter Laura	Chief Scientific Officer	S Sale	2022-10-24	2022-10-25	4,876	$12.07	$58.9K	82,292	SEC↗
Peterson Caryn	EVP, Regulatory Affairs	S Sale	2022-10-24	2022-10-25	4,757	$12.07	$57.4K	61,415	SEC↗
Carter Laura	Chief Scientific Officer	S Sale	2022-10-24	2022-10-27	4,876	$12.07	$58.9K	82,292	SEC↗
Hasnain Faheem	President & CEO	P Buy	2022-07-15	2022-07-15	138,696	$7.21	$1000.0K	3,617,325	SEC↗
Giraudo Bryan	COO/CFO	P Buy	2022-07-15	2022-07-15	13,869	$7.21	$100.0K	20,990	SEC↗
Christian Waage	EVP, Tech Ops and Admin	P Buy	2022-07-15	2022-07-15	6,934	$7.21	$50.0K	13,888	SEC↗
Carter Laura	Chief Scientific Officer	P Buy	2022-07-15	2022-07-15	6,934	$7.21	$50.0K	87,168	SEC↗
Carter Laura	Chief Scientific Officer	S Sale	2022-07-01	2022-07-05	8,808	$8.25	$72.7K	80,234	SEC↗
Aranda Richard	Chief Medical Officer	S Sale	2022-06-22	2022-06-23	1,778	$6.88	$12.2K	209,897	SEC↗
GALA RENEE D	Director	A Award deriv	2022-06-09	2022-07-15	30,000	—	$0	30,000	SEC↗
Milligan Sandra	Director	A Award deriv	2022-06-09	2022-07-15	30,000	—	$0	30,000	SEC↗
Bilenker Joshua H.	Director	A Award deriv	2022-06-09	2022-07-15	30,000	—	$0	30,000	SEC↗
Cox Russell J.	Director	A Award deriv	2022-06-09	2022-07-15	30,000	—	$0	30,000	SEC↗
Daniel Thomas O	Director	A Award deriv	2022-06-09	2022-07-15	30,000	—	$0	30,000	SEC↗
Burow Kristina	Director	A Award deriv	2022-06-09	2022-07-15	30,000	—	$0	30,000	SEC↗